Susquehanna International Group
TPI

Susquehanna International Group’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Susquehanna International Group’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,000
Closed -$15K – 10408
2014
Q4 		$15K Buy
+20,000
New +$11K ﹤0.01% 9500

Other funds holding TPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAM
Pope Asset Management Memphis, Tennessee $162M AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's TPI Position: Q1 2015 in Review

Susquehanna International Group sold out of TIANYIN PHARMACEUTICAL (TPI) in Q1 2015, closing a stake of 20,000 shares — an estimated $15K sold.

Susquehanna International Group first reported a position in TPI in Q4 2014 and held it in 1 quarter. The position peaked at $15K in Q4 2014. 9 funds tracked by Wall St. Rank hold TPI as of Q1 2015.

  • Susquehanna International Group reported no remaining TIANYIN PHARMACEUTICAL position as of Q1 2015 after selling out during the quarter.
  • Susquehanna International Group sold 20,000 TIANYIN PHARMACEUTICAL shares in Q1 2015, an estimated $15K.
  • Susquehanna International Group first reported a position in TIANYIN PHARMACEUTICAL in Q4 2014 and held it in 1 quarter.
  • Susquehanna International Group's TIANYIN PHARMACEUTICAL position peaked at $15K in Q4 2014.
  • 9 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q1 2015.

Based on Susquehanna International Group's 13F filing for Q1 2015, filed 15 May 2015.